Resultats de la cerca - Jason Roszik

Refinar resultats
  1. 1
    AccPbFRET: An ImageJ plugin for semi-automatic, fully corrected analysis of acceptor photobleaching FRET images

    AccPbFRET: An ImageJ plugin for semi-automatic, fully corrected analysis of acceptor photobleaching FRET images per Jason Roszik, János Szöllősi, György Vereb

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Targeting iNOS to increase efficacy of immunotherapies

    Targeting iNOS to increase efficacy of immunotherapies per Sühendan Ekmekçioglu, Elizabeth A. Grimm, Jason Roszik

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    mTOR at the Transmitting and Receiving Ends in Tumor Immunity

    mTOR at the Transmitting and Receiving Ends in Tumor Immunity per Yakir Guri, Thierry M. Nordmann, Jason Roszik

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Evaluation of intensity‐based ratiometric FRET in image cytometry—Approaches and a software solution

    Evaluation of intensity‐based ratiometric FRET in image cytometry—Approaches and a software solution per Jason Roszik, Duarte Lisboa, János Szöllősi, György Vereb

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy

    Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy per Yiliang Li, Sapna P. Patel, Jason Roszik, Yong Qin

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches

    Exploiting Tumor Neoantigens to Target Cancer Evolution: Current Challenges and Promising Therapeutic Approaches per Ravi G. Gupta, Fenge Li, Jason Roszik, Gregory Lizée

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy

    Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy per Sun-Hee Kim, Jason Roszik, Elizabeth A. Grimm, Sühendan Ekmekçioglu

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Targeting KRAS in Cancer: Promising Therapeutic Strategies

    Targeting KRAS in Cancer: Promising Therapeutic Strategies per Lisa Maria Mustachio, Anca Chelariu-Raicu, Lóránt Székvölgyi, Jason Roszik

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies

    Analysis of <i>MDM2</i> Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies per Shumei Kato, Jeffrey S. Ross, Laurie M. Gay, Farshid Dayyani, Jason Roszik, Vivek Subbiah, Razelle Kurzrock

    Publicat 2018
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Hallmarks of RET and Co-occuring Genomic Alterations in<i>RET</i>-aberrant Cancers

    Hallmarks of RET and Co-occuring Genomic Alterations in<i>RET</i>-aberrant Cancers per Jacob J. Adashek, Aakash Desai, Alexander Andreev-Drakhlin, Jason Roszik, Gilbert J. Cote, Vivek Subbiah

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors

    Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors per Jacob J. Adashek, Arjun K. Menta, Neha K. Reddy, Aakash Desai, Jason Roszik, Vivek Subbiah

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target

    Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target per Lisa Maria Mustachio, Yun Lu, Masanori Kawakami, Jason Roszik, Sarah J. Freemantle, Xi Liu, Ethan Dmitrovsky

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators

    Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators per Yong Qin, Sühendan Ekmekçioglu, Marie-Andrée Forget, Lóránt Székvölgyi, Patrick Hwu, Elizabeth A. Grimm, Amir A. Jazaeri, Jason Roszik

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer

    The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer per Boris Sepesi, Kathryn A. Gold, Arlene M. Correa, John V. Heymach, Ara A. Vaporciyan, Jason Roszik, Ethan Dmitrovsky, Xi Liu

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma

    Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma per Kartik Anand, Jason Roszik, Dan S. Gombos, Joshua Upshaw, Vanessa N. Sarli, Salyna Meas, Anthony Lucci, Carolyn Hall, Sapna P. Patel

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    NLRC5/MHC class I transactivator is a target for immune evasion in cancer

    NLRC5/MHC class I transactivator is a target for immune evasion in cancer per Sayuri Yoshihama, Jason Roszik, Isaac Downs, Torsten Meißner, Saptha Vijayan, Bjoern Chapuy, Tabasum Sidiq, Margaret A. Shipp, Gregory Lizée, Koichi S. Kobayashi

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    The COX2 effector microsomal PGE2 synthase-1 is a regulator of immunosuppression in cutaneous melanoma

    The COX2 effector microsomal PGE2 synthase-1 is a regulator of immunosuppression in cutaneous melanoma per Kim, Sun-Hee, Jason, Roszik, Cho, Sungnam, Ogata, Dai, Milton, Denái R., Peng, Weiyi, Menter, David G., Ekmekcioglu, Suhendan, Grimm, Elizabeth A.

    Publicat 2018
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  18. 18
    Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma

    Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma per Yong Qin, Jason Roszik, Chandrani Chattopadhyay, Yuuri Hashimoto, Chengwen Liu, Zachary A. Cooper, Jennifer A. Wargo, Patrick Hwu, Sühendan Ekmekçioğlu, Elizabeth A. Grimm

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma

    The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma per Sun-Hee Kim, Jason Roszik, Sung-Nam Cho, Dai Ogata, Denái R. Milton, Weiyi Peng, David G. Menter, Sühendan Ekmekçioğlu, Elizabeth A. Grimm

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    mTORC2 Promotes Tumorigenesis via Lipid Synthesis

    mTORC2 Promotes Tumorigenesis via Lipid Synthesis per Yakir Guri, Marco Colombi, Eva Dazert, Sravanth K. Hindupur, Jason Roszik, Suzette Moes, Paul Jenoe, Markus H. Heim, Isabelle Riezman, Howard Riezman, Michael N. Hall

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: